1. Home
  2. DRUG vs RITR Comparison

DRUG vs RITR Comparison

Compare DRUG & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • RITR
  • Stock Information
  • Founded
  • DRUG 2019
  • RITR 2015
  • Country
  • DRUG United States
  • RITR Hong Kong
  • Employees
  • DRUG N/A
  • RITR N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • RITR
  • Sector
  • DRUG Health Care
  • RITR
  • Exchange
  • DRUG Nasdaq
  • RITR NYSE
  • Market Cap
  • DRUG 210.7M
  • RITR 249.8M
  • IPO Year
  • DRUG N/A
  • RITR 2024
  • Fundamental
  • Price
  • DRUG $32.38
  • RITR $4.60
  • Analyst Decision
  • DRUG
  • RITR
  • Analyst Count
  • DRUG 0
  • RITR 0
  • Target Price
  • DRUG N/A
  • RITR N/A
  • AVG Volume (30 Days)
  • DRUG 382.4K
  • RITR 186.8K
  • Earning Date
  • DRUG 11-26-2024
  • RITR 11-26-2024
  • Dividend Yield
  • DRUG N/A
  • RITR N/A
  • EPS Growth
  • DRUG N/A
  • RITR N/A
  • EPS
  • DRUG N/A
  • RITR 0.04
  • Revenue
  • DRUG N/A
  • RITR $32,198,033.00
  • Revenue This Year
  • DRUG N/A
  • RITR N/A
  • Revenue Next Year
  • DRUG N/A
  • RITR N/A
  • P/E Ratio
  • DRUG N/A
  • RITR $108.84
  • Revenue Growth
  • DRUG N/A
  • RITR 74.80
  • 52 Week Low
  • DRUG $0.93
  • RITR $3.30
  • 52 Week High
  • DRUG $79.02
  • RITR $8.75
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 43.69
  • RITR N/A
  • Support Level
  • DRUG $36.02
  • RITR N/A
  • Resistance Level
  • DRUG $44.70
  • RITR N/A
  • Average True Range (ATR)
  • DRUG 5.79
  • RITR 0.00
  • MACD
  • DRUG -3.22
  • RITR 0.00
  • Stochastic Oscillator
  • DRUG 6.26
  • RITR 0.00

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About RITR REITAR LOGTECH HLDGS LTD

Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.

Share on Social Networks: